Aspen Aerogels (ASPN) Scheduled to Post Earnings on Wednesday

Aspen Aerogels (NYSE:ASPN) is set to post its quarterly earnings results after the market closes on Wednesday, November 6th. Analysts expect Aspen Aerogels to post earnings of ($0.01) per share for the quarter. Aspen Aerogels has set its FY24 guidance at more than $0.09 EPS.Individual interested in registering for the company’s earnings conference call can do so using this link.

Aspen Aerogels (NYSE:ASPN) last issued its quarterly earnings results on Wednesday, August 7th. The construction company reported $0.21 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.16. The company had revenue of $117.80 million for the quarter, compared to analyst estimates of $101.99 million. Aspen Aerogels had a net margin of 0.39% and a return on equity of 0.74%. Aspen Aerogels’s revenue was up 144.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.22) earnings per share. On average, analysts expect Aspen Aerogels to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Aspen Aerogels Stock Performance

NYSE ASPN opened at $18.23 on Wednesday. The company has a market capitalization of $1.39 billion, a price-to-earnings ratio of -41.43 and a beta of 2.16. The company has a quick ratio of 2.82, a current ratio of 3.46 and a debt-to-equity ratio of 0.23. Aspen Aerogels has a twelve month low of $7.17 and a twelve month high of $33.15. The stock has a fifty day simple moving average of $25.01 and a 200 day simple moving average of $24.61.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on ASPN shares. Piper Sandler lowered their price objective on Aspen Aerogels from $36.00 to $33.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Benchmark restated a “buy” rating and set a $14.00 price target on shares of Aspen Aerogels in a report on Thursday, August 8th. Roth Mkm restated a “buy” rating and issued a $36.00 price target on shares of Aspen Aerogels in a research report on Wednesday, August 21st. TD Cowen increased their price objective on shares of Aspen Aerogels from $36.00 to $41.00 and gave the stock a “buy” rating in a research report on Tuesday, August 20th. Finally, HC Wainwright restated a “buy” rating and issued a $30.00 target price on shares of Aspen Aerogels in a report on Wednesday, October 16th. One investment analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $29.40.

Insider Buying and Selling at Aspen Aerogels

In other news, CFO Ricardo C. Rodriguez sold 32,465 shares of the stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares of the company’s stock, valued at $626,610.60. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In related news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the completion of the sale, the chief executive officer now owns 483,640 shares of the company’s stock, valued at approximately $14,523,709.20. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company’s stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares in the company, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 4.30% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.